IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

VITIELLO, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.330
EU - Europa 1.022
AS - Asia 836
SA - Sud America 104
AF - Africa 22
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.319
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.270
GB - Regno Unito 289
CN - Cina 259
SG - Singapore 238
IT - Italia 198
DE - Germania 163
SE - Svezia 90
BR - Brasile 77
HK - Hong Kong 62
VN - Vietnam 62
RU - Federazione Russa 59
FR - Francia 52
CA - Canada 50
BD - Bangladesh 46
IN - India 46
NL - Olanda 36
FI - Finlandia 33
TR - Turchia 29
UA - Ucraina 28
KR - Corea 24
ID - Indonesia 23
IE - Irlanda 23
BE - Belgio 20
JP - Giappone 18
EU - Europa 17
CO - Colombia 10
CI - Costa d'Avorio 8
MX - Messico 7
GR - Grecia 6
AR - Argentina 5
AT - Austria 5
AE - Emirati Arabi Uniti 4
VE - Venezuela 4
ZA - Sudafrica 4
AU - Australia 3
CL - Cile 3
EC - Ecuador 3
ES - Italia 3
IQ - Iraq 3
MA - Marocco 3
PK - Pakistan 3
PL - Polonia 3
RO - Romania 3
SM - San Marino 3
BG - Bulgaria 2
CH - Svizzera 2
EE - Estonia 2
ET - Etiopia 2
KE - Kenya 2
LA - Repubblica Popolare Democratica del Laos 2
NP - Nepal 2
PH - Filippine 2
SA - Arabia Saudita 2
UY - Uruguay 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AZ - Azerbaigian 1
DO - Repubblica Dominicana 1
ER - Eritrea 1
GA - Gabon 1
IL - Israele 1
IR - Iran 1
KH - Cambogia 1
KZ - Kazakistan 1
LT - Lituania 1
MD - Moldavia 1
MW - Malawi 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
TW - Taiwan 1
Totale 3.335
Salva come PNG Salva come JPEG
Città #
Southend 249
Singapore 140
Chandler 125
Ashburn 124
Fairfield 81
Ann Arbor 60
Beijing 59
Milan 54
San Jose 53
Hong Kong 52
Wilmington 52
Seattle 49
Woodbridge 45
Houston 41
Santa Clara 41
Princeton 40
Los Angeles 38
Cambridge 36
Council Bluffs 35
Mountain View 27
Boise 24
Dearborn 24
Dublin 23
Helsinki 21
Toronto 21
Brussels 20
Dallas 20
New York 20
Montreal 19
Redmond 18
Boardman 17
Ho Chi Minh City 17
Jakarta 17
Kiez 15
Nanjing 15
Buffalo 14
Somerville 14
Margão 13
Phoenix 13
São Paulo 13
Bengaluru 12
Frankfurt am Main 12
Lauterbourg 12
Tokyo 12
Cangzhou 11
Rome 11
Seoul 11
Des Moines 10
Hanoi 10
Andover 9
Guangzhou 9
Sakarya 9
Shenzhen 9
The Dalles 9
Bogotá 8
Columbus 8
Dong Ket 8
Eitensheim 8
Falls Church 8
Florence 8
Munich 8
Hefei 7
Moscow 7
Nürnberg 7
Padova 7
Athens 6
Hamburg 6
Jacksonville 6
Redwood City 6
Shanghai 6
Abidjan 5
Da Nang 5
Fremont 5
Hangzhou 5
Naples 5
Odernheim 5
Silver Spring 5
Turin 5
Atlanta 4
Bari 4
Changsha 4
Chennai 4
Grafing 4
Hebei 4
Jinan 4
Nuremberg 4
Shenyang 4
Berlin 3
Budenheim 3
Cagliari 3
Catanzaro 3
Cattolica 3
Chicago 3
Evanston 3
Falciano 3
Genoa 3
Kiel 3
Kwai Chung 3
Lanzhou 3
Montréal 3
Totale 2.134
Salva come PNG Salva come JPEG
Nome #
Maraviroc as Intensification Strategy in HIV-1 Positive Patients with Deficient Immunological Response: an Italian Randomized Clinical Trial 367
Prevalence of mutations and determinants of genotypic resistance to etravirine (TMC125) in a large Italian resistance database (ARCA) 333
Evolution of the HIV-1 protease region in heavily pretreated HIV-1 infected patients receiving Atazanavir 332
Comparative evaluation of seven resistance interpretation algorithms and their derived genotypic inhibitory quotients for the prediction of 48 week virological response to darunavir-based salvage regimens 324
Does GSS Still Maintain Relevance on HAART Outcome After the Introduction of Newest Active Antiretroviral Drugs? 48 Weeks Results 309
Maraviroc intensification for HIV-1-positive immunological non-responders (INRs) despite virological suppression during HAART 293
Efficacy of Maraviroc (MVC) as intensification strategy in immunological non-responder (INR) HIV-1-infected patients treated with HAART 242
96-week results of a dual therapy with darunavir/ritonavir plus rilpivirine once a day vs triple therapy in patients with suppressed viraemia: virological success and non-HIV related morbidity evaluation 238
Maraviroc : un inibitore del co-recettore CCR5 con un unico profilo di efficacia e tollerabilita’ in diversi scenari clinici dell'infezione da HIV-1 214
Severe raltegravir-associated rhabdomyolysis: a case report and review of the literature 185
Determinants of virological response to raltegravir (RAL)-containing regimens and prevalence of RAL-resistance associated mutations at failure in ARCA 175
Levofloxacin-induced seizures in a patient without predisposing risk factors : the impact of pharmacogenetics 168
Factors associated with virological success with raltegravir-containing regimens and prevalence of raltegravir-resistance-associated mutations at failure in the ARCA database 153
Switch from unboosted protease inhibitor to a single-tablet regimen containing rilpivirine improves cholesterol and triglycerides 126
Totale 3.459
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.062
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.062
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202165 0 0 0 0 0 0 0 0 0 0 52 13
2021/2022261 31 14 11 8 13 20 21 18 30 29 17 49
2022/2023312 51 50 37 32 24 49 8 15 30 0 14 2
2023/2024158 3 12 4 17 25 13 4 18 1 14 9 38
2024/2025412 7 27 5 52 38 24 11 43 36 41 33 95
2025/2026880 91 59 58 65 99 64 113 33 87 62 149 0
Totale 3.459